Declaration Partners, a private equity firm, led a $150m Series B funding round in Concerto HealthAI, a provider of RWD and enterprise AI technology solutions for precision oncology. The funding round saw participation from Maverick Ventures, AllianceBernstein, and SymphonyAI Group. "We are pleased to partner with industry visionaries and proven business leaders like Romesh Wadhwani and Jeff Elton to bring a range of forward-looking data and technology solutions to the market, We are impressed with Concerto HealthAI’s innovative culture, technology leadership, and significant runway for growth. Concerto HealthAI is positioned to empower next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes," Andrew Goldfarb, Declaration Partner.